Style | Citing Format |
---|---|
MLA | Shahi A, et al.. "Il-27 and Autoimmune Rheumatologic Diseases: The Good, the Bad, and the Ugly." International Immunopharmacology, vol. 84, no. , 2020, pp. -. |
APA | Shahi A, Afzali S, Salehi S, Aslani S, Mahmoudi M, Jamshidi A, Amirzargar A (2020). Il-27 and Autoimmune Rheumatologic Diseases: The Good, the Bad, and the Ugly. International Immunopharmacology, 84(), -. |
Chicago | Shahi A, Afzali S, Salehi S, Aslani S, Mahmoudi M, Jamshidi A, Amirzargar A. "Il-27 and Autoimmune Rheumatologic Diseases: The Good, the Bad, and the Ugly." International Immunopharmacology 84, no. (2020): -. |
Harvard | Shahi A et al. (2020) 'Il-27 and Autoimmune Rheumatologic Diseases: The Good, the Bad, and the Ugly', International Immunopharmacology, 84(), pp. -. |
Vancouver | Shahi A, Afzali S, Salehi S, Aslani S, Mahmoudi M, Jamshidi A, et al.. Il-27 and Autoimmune Rheumatologic Diseases: The Good, the Bad, and the Ugly. International Immunopharmacology. 2020;84():-. |
BibTex | @article{ author = {Shahi A and Afzali S and Salehi S and Aslani S and Mahmoudi M and Jamshidi A and Amirzargar A}, title = {Il-27 and Autoimmune Rheumatologic Diseases: The Good, the Bad, and the Ugly}, journal = {International Immunopharmacology}, volume = {84}, number = {}, pages = {-}, year = {2020} } |
RIS | TY - JOUR AU - Shahi A AU - Afzali S AU - Salehi S AU - Aslani S AU - Mahmoudi M AU - Jamshidi A AU - Amirzargar A TI - Il-27 and Autoimmune Rheumatologic Diseases: The Good, the Bad, and the Ugly JO - International Immunopharmacology VL - 84 IS - SP - EP - PY - 2020 ER - |